Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1793)	1/16/2008 12:18:00 PM
From: Jibacoa	Read Replies (1) of 3722

ISTA seems to have support at the $4.75 level. The stock is up 7.34% with volume still below its ADV & no news that I am aware.<g> bigcharts.marketwatch.com ISTA has 4Qs of double digit improvement on revenues & has been trimming its losses. In the 3rdQ its sales were the highest ever, as Xibrom's market share continued to improve. ISTA wants to be among the leading providers of ophthalmic pharmaceuticals, but it is starting to take some steps in expanding its reach beyond the ophthalmic market with the licensing of nasal bepotastine.<g> With some improvement on the general market's mood it seems that ISTA could get to trade at the $10 level.(That would be a little above the analyst's consensus target around $9.90 & of course, it would have to deal with the significant resistance from the $7 to the $8 level. <g>) bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next